Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial

This randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge incontinence due to an overactive bladder (OAB). From February 20...

Full description

Bibliographic Details
Main Authors: Álvaro Zapico, Julia Ercilla, Javier C. Angulo, Vicente Pérez, Juan Nicolás Cuenca, Diana Barreira-Hernández, Carlos Udina-Cortés
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/3/759
_version_ 1797624166016352256
author Álvaro Zapico
Julia Ercilla
Javier C. Angulo
Vicente Pérez
Juan Nicolás Cuenca
Diana Barreira-Hernández
Carlos Udina-Cortés
author_facet Álvaro Zapico
Julia Ercilla
Javier C. Angulo
Vicente Pérez
Juan Nicolás Cuenca
Diana Barreira-Hernández
Carlos Udina-Cortés
author_sort Álvaro Zapico
collection DOAJ
description This randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge incontinence due to an overactive bladder (OAB). From February 2019 to May 2021, 66 patients were recruited. All subjects were randomized 1:1 at the first intervention visit to the NAT or sham procedure. Inclusion criteria were females between 18 and 80 years old with leakages due to an overactive bladder with unresponsiveness to medical therapy. Subjects were scheduled to receive up to eight weekly 20 min intervention sessions to obtain a complete (CR) or partial response (PR). Patients with no response after three sessions were considered as a failure. The primary end point of this trial was to assess the efficacy of NAT compared to an inactive sham intervention, evaluated 1 month after the last session. Analysis showed 23 (70%) patients responded (20 complete and 3 partial response) in the NAT group compared to 16 (48%) patients (all complete response) in the placebo arm (<i>p</i> = 0.014). Significant differences were maintained after the intervention, with persistent response at 3 months in 19 (58%) patients after active treatment and 14 (42%) after the placebo (<i>p</i> < 0.001), and at 6 months in 18 (55%) vs. 11 (33%) (<i>p</i> = 0.022), respectively. The number of sessions to achieve CR was similar in both arms, with 4.3 ± 1.9 in NAT and 3.9 ± 1.8 in the sham group (NS). Significant differences were observed between both groups for patients’ satisfaction (<i>p</i> = 0.01). The binary model selected age as a predictor of response at the last follow-up. The odds ratio indicates that each year of increase in age, the probability of a positive response to treatment at 6 months decreases 0.95 (95% CI 0.9–0.99) times (<i>p</i> = 0.03). In conclusion, this pilot randomized trial gives evidence that neuro-adaptive electrostimulation is effective to treat refractory urge urinary incontinence due to OAB. The security and long-term efficacy of this treatment merits further evaluation. Moreover, its favorable profile and the economic advantages of the device make the evaluation of this promising technique mandatory in a primary therapeutic scenario.
first_indexed 2024-03-11T09:39:15Z
format Article
id doaj.art-c43cc21c80c3420ba91df4d28d91ffee
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T09:39:15Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-c43cc21c80c3420ba91df4d28d91ffee2023-11-16T17:06:48ZengMDPI AGJournal of Clinical Medicine2077-03832023-01-0112375910.3390/jcm12030759Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded TrialÁlvaro Zapico0Julia Ercilla1Javier C. Angulo2Vicente Pérez3Juan Nicolás Cuenca4Diana Barreira-Hernández5Carlos Udina-Cortés6Department of Obstetrics and Gynecology, Hospital Universitario Príncipe de Asturias, 28802 Alcalá de Henares, SpainDepartment of Obstetrics and Gynecology, Hospital Universitario Príncipe de Asturias, 28802 Alcalá de Henares, SpainDepartment of Urology, Hospital Universitario de Getafe, 28905 Getafe, SpainDepartment of Obstetrics and Gynecology, Hospital Universitario Príncipe de Asturias, 28802 Alcalá de Henares, SpainNursing and Physiotherapy Department, Universidad de Alcalá, 28802 Alcalá de Henares, SpainDepartment of Biomedical Sciences, Universidad de Alcalá, 28802 Alcalá de Henares, SpainInstitute Neurolife, 28034 Madrid, SpainThis randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge incontinence due to an overactive bladder (OAB). From February 2019 to May 2021, 66 patients were recruited. All subjects were randomized 1:1 at the first intervention visit to the NAT or sham procedure. Inclusion criteria were females between 18 and 80 years old with leakages due to an overactive bladder with unresponsiveness to medical therapy. Subjects were scheduled to receive up to eight weekly 20 min intervention sessions to obtain a complete (CR) or partial response (PR). Patients with no response after three sessions were considered as a failure. The primary end point of this trial was to assess the efficacy of NAT compared to an inactive sham intervention, evaluated 1 month after the last session. Analysis showed 23 (70%) patients responded (20 complete and 3 partial response) in the NAT group compared to 16 (48%) patients (all complete response) in the placebo arm (<i>p</i> = 0.014). Significant differences were maintained after the intervention, with persistent response at 3 months in 19 (58%) patients after active treatment and 14 (42%) after the placebo (<i>p</i> < 0.001), and at 6 months in 18 (55%) vs. 11 (33%) (<i>p</i> = 0.022), respectively. The number of sessions to achieve CR was similar in both arms, with 4.3 ± 1.9 in NAT and 3.9 ± 1.8 in the sham group (NS). Significant differences were observed between both groups for patients’ satisfaction (<i>p</i> = 0.01). The binary model selected age as a predictor of response at the last follow-up. The odds ratio indicates that each year of increase in age, the probability of a positive response to treatment at 6 months decreases 0.95 (95% CI 0.9–0.99) times (<i>p</i> = 0.03). In conclusion, this pilot randomized trial gives evidence that neuro-adaptive electrostimulation is effective to treat refractory urge urinary incontinence due to OAB. The security and long-term efficacy of this treatment merits further evaluation. Moreover, its favorable profile and the economic advantages of the device make the evaluation of this promising technique mandatory in a primary therapeutic scenario.https://www.mdpi.com/2077-0383/12/3/759overactive bladderurinary incontinenceneuromodulationneurostimulationneuro-adaptive therapySCENAR
spellingShingle Álvaro Zapico
Julia Ercilla
Javier C. Angulo
Vicente Pérez
Juan Nicolás Cuenca
Diana Barreira-Hernández
Carlos Udina-Cortés
Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
Journal of Clinical Medicine
overactive bladder
urinary incontinence
neuromodulation
neurostimulation
neuro-adaptive therapy
SCENAR
title Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_full Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_fullStr Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_full_unstemmed Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_short Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
title_sort effect of neuro adaptive electrostimulation therapy versus sham for refractory urge urinary incontinence due to overactive bladder a randomized single blinded trial
topic overactive bladder
urinary incontinence
neuromodulation
neurostimulation
neuro-adaptive therapy
SCENAR
url https://www.mdpi.com/2077-0383/12/3/759
work_keys_str_mv AT alvarozapico effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT juliaercilla effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT javiercangulo effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT vicenteperez effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT juannicolascuenca effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT dianabarreirahernandez effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial
AT carlosudinacortes effectofneuroadaptiveelectrostimulationtherapyversusshamforrefractoryurgeurinaryincontinenceduetooveractivebladderarandomizedsingleblindedtrial